PHAT - Phathom Pharmaceuticals, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Florham Park,
United States
Type: Equity
PHAT price evolution
PHAT
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $279.1 | $325.1 | $384.26 | |
| Short term investments | ||||
| Net receivables | $21.05 | $10.88 | $3.88 | $1.64 |
| Inventory | $3.11 | $9.35 | $9.86 | $9.44 |
| Total current assets | $373.82 | $304.79 | $340.31 | $397.43 |
| Long term investments | ||||
| Property, plant & equipment | $2.49 | $2.86 | $3.23 | $3.62 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $14.59 | $16.18 | $16.41 | |
| Total investments | ||||
| Total assets | $387.04 | $319.38 | $356.5 | $413.84 |
| Current liabilities | ||||
| Accounts payable | $7.13 | $7.66 | $8.4 | $12.6 |
| Deferred revenue | ||||
| Short long term debt | $0.72 | $0.73 | $0.73 | |
| Total current liabilities | $65.29 | $47.01 | $43.46 | $38.78 |
| Long term debt | $498.12 | $495.75 | $451.84 | $438.12 |
| Total noncurrent liabilities | $506.2 | $461.54 | $447.82 | |
| Total debt | $496.47 | $452.57 | $438.85 | |
| Total liabilities | $574.16 | $553.21 | $505 | $486.6 |
| Shareholders' equity | ||||
| Retained earnings | -$1188.56 | -$1102.98 | -$1011.54 | -$928.68 |
| Other shareholder equity | ||||
| Total shareholder equity | -$233.83 | -$148.5 | -$72.76 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $384.26 | $155.89 | $183.26 | $287.5 |
| Short term investments | ||||
| Net receivables | $1.64 | |||
| Inventory | $9.44 | |||
| Total current assets | $397.43 | $160.51 | $186.53 | $291.37 |
| Long term investments | ||||
| Property, plant & equipment | $3.62 | $3.49 | $2.56 | $3.36 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $16.41 | $4.3 | $2.9 | $3.74 |
| Total investments | ||||
| Total assets | $413.84 | $164.81 | $189.43 | $295.11 |
| Current liabilities | ||||
| Accounts payable | $12.6 | $10 | $5.15 | $16.78 |
| Deferred revenue | ||||
| Short long term debt | $0.73 | $0.71 | $0.49 | $7.83 |
| Total current liabilities | $38.78 | $26.24 | $18.92 | $55.52 |
| Long term debt | $438.12 | $204.79 | $90.85 | $41.19 |
| Total noncurrent liabilities | $447.82 | $213.39 | $98.35 | $45.32 |
| Total debt | $438.85 | $206.59 | $91.34 | $49.02 |
| Total liabilities | $486.6 | $239.62 | $117.28 | $100.84 |
| Shareholders' equity | ||||
| Retained earnings | -$928.68 | -$727.09 | -$529.37 | -$385.49 |
| Other shareholder equity | ||||
| Total shareholder equity | -$72.76 | -$74.81 | $72.16 | $194.27 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $16.35 | $7.32 | $1.91 | $0.68 |
| Cost of revenue | $1.38 | $0.43 | $0.17 | |
| Gross Profit | $14 | $5.95 | $1.49 | $0.52 |
| Operating activities | ||||
| Research & development | $7.38 | $9.43 | $13.39 | |
| Selling, general & administrative | $75.87 | $62.01 | $57 | |
| Total operating expenses | $84.79 | $83.25 | $71.44 | $70.39 |
| Operating income | -$77.3 | -$69.95 | -$69.88 | |
| Income from continuing operations | ||||
| EBIT | -$73.68 | -$65.68 | -$66.54 | |
| Income tax expense | ||||
| Interest expense | -$14.77 | $17.76 | $17.17 | $13.03 |
| Net income | ||||
| Net income | -$85.58 | -$91.45 | -$82.85 | -$79.57 |
| Income (for common shares) | -$91.45 | -$82.85 | -$79.57 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.68 | |||
| Cost of revenue | $0.17 | |||
| Gross Profit | $0.52 | |||
| Operating activities | ||||
| Research & development | $49.9 | $71.44 | $72.34 | $98.15 |
| Selling, general & administrative | $117.93 | $101 | $62.74 | $27.52 |
| Total operating expenses | $167.83 | $172.44 | $135.08 | $125.67 |
| Operating income | -$167.31 | -$172.44 | -$135.08 | -$125.67 |
| Income from continuing operations | ||||
| EBIT | -$159.62 | -$170.42 | -$137.09 | -$124.49 |
| Income tax expense | ||||
| Interest expense | $41.97 | $27.3 | $6.79 | $4.58 |
| Net income | ||||
| Net income | -$201.59 | -$197.72 | -$143.88 | -$129.07 |
| Income (for common shares) | -$201.59 | -$197.72 | -$143.88 | -$129.07 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$91.45 | -$82.85 | -$79.57 | |
| Operating activities | ||||
| Depreciation | $0.2 | $0.21 | $0.18 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6.1 | $5.63 | $24.58 | |
| Total cash flows from operations | -$70.72 | -$69.02 | -$43.8 | |
| Investing activities | ||||
| Capital expenditures | -$0.05 | -$0.04 | -$0.47 | |
| Investments | ||||
| Total cash flows from investing | -$0.13 | -$0.05 | -$0.04 | -$0.47 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.02 | |||
| Net borrowings | $24.75 | $9.9 | $211.99 | |
| Total cash flows from financing | $156.73 | $24.77 | $9.9 | $211.99 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$46.72 | -$46 | -$59.16 | $167.72 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$201.59 | -$197.72 | -$143.88 | -$129.07 |
| Operating activities | ||||
| Depreciation | $0.57 | $0.62 | $0.52 | $0.32 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $45.02 | $24.13 | $16.81 | $5.84 |
| Total cash flows from operations | -$137.58 | -$146.53 | -$148.62 | -$69.69 |
| Investing activities | ||||
| Capital expenditures | -$1.63 | -$1.04 | -$0.33 | -$1.04 |
| Investments | ||||
| Total cash flows from investing | -$1.63 | -$1.04 | -$0.33 | -$1.04 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $155.59 | $24.6 | $1.94 | $89.46 |
| Net borrowings | $211.99 | $95.45 | $42.76 | $25 |
| Total cash flows from financing | $367.58 | $120.04 | $44.71 | $114.46 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $228.37 | -$27.53 | -$104.24 | $43.73 |
News
Fundamentals
| Market cap | $394.23M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 68.32M |
| Revenue | $26.27M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$339.44M |
| Revenue Q/Q | InfinityT% |
| Revenue Y/Y | N/A |
| P/E ratio | -1.16 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 15.01 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$4.97 |
|---|---|
| ROA | -91.94% |
| ROE | N/A |
| Debt/Equity | -6.69 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 5.73 |
| Quick ratio | 5.68 |